Evidence map›Paper›PMID 41003843›Full record

ArticleDiscover oncology2025

Comparison of random survival forest and Cox regression for long-term prognosis of pediatric Wilms tumor: based on the SEER database and external validation cohort from China.

Honggang Fang, Junjun Dong, Qinglin Shi, Guanghui Wei, Xing Liu, Shengde Wu, Yi Hua, Dawei He, Qi Li, Deying Zhang

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Honggang Fang *Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Junjun Dong *Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Qinglin ShiDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Guanghui WeiDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Xing LiuDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Shengde WuDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yi HuaDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Dawei HeDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Qi LiSchool of Finance, Chongqing Technology and Business University, Chongqing, China. liqi1@ctbu.edu.cn.
Deying ZhangDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China. zdy@hospital.cqmu.edu.cn.

Funding

the Chongqing Key Project of Technology Innovation and Application 2024TIAD-KPX0035the Joint Project of the Chongqing Health Commission and Science and Technology Bureau 2025ZDXM038
6 · The paper itself

Abstract

backgroundWilms tumor (WT) is the most common malignant renal tumor in children. Despite advances in treatment, accurate prediction of the long-term prognosis remains challenging. Various Cox regression-based models have been developed to assess WT survival rates; however, there is a pressing need for more precise tools.

methodsData from the SEER database (2000-2021) and external validation data from Chongqing Medical University Children's Hospital were utilized. Key prognostic factors for children with WT were identified via last absolute shrinkage and selection operator (LASSO) regression, which was subsequently used to construct the Random Survival Forest(RSF) model for long-term survival prediction. SHAP were applied to enhance the interpretability of the model. The model performance was compared to that of conventional Cox models via calibration curves, the Concordance index (C-index), the net reclassification index (NRI), and the integrated discrimination index (IDI).

resultsWe included 1,629 children with WT from the SEER database and externally validated the model via data from 169 children at Children's Hospital of Chongqing Medical University(CHCMU). Kaplan‒Meier curves revealed higher mortality rates for Chinese children with WT than for their counterparts in the United States. LASSO regression identified six key variables for the development of the RSF and Cox models. The SHAP method was utilized to rank these variables in descending order of importance: tumor stage, age, lymph node density(LND), tumor metastasis, number of positive lymph nodes, and laterality (unilateral/bilateral). The RSF model demonstrated superior predictive performance and generalizability, as indicated by Brier scores, calibration curves, AUC curves, and risk curves. Moreover, the RSF model significantly outperformed the Cox model in terms of prediction accuracy (C-index: 0.868 vs. 0.759), with substantial improvements in the NRI and IDI (P < 0.01). Decision curve analysis also revealed that the RSF model provided a greater net benefit at 3, 5, and 7 years than did the Cox model, which underscored the greater clinical utility of the RSF model. Sensitivity analysis based on imputed data confirmed the robustness of the model, with consistent predictor selection and comparable performance metrics, further supported the stability and reliability of the RSF framework.

conclusionWe successfully developed a robust machine learning model that accurately assesses key prognostic factors affecting the long-term survival of children with WT. This model offers substantial clinical value for risk stratification and can assist clinicians in making more informed treatment decisions. By applying SHAP analysis, physicians can better understand the critical factors influencing WT prognosis and tailor intervention strategies more precisely.

Indexed as

Cox regressionLong-Term prognosisRandom survival forestSEER databaseWilms tumor

Identifiers

PMID41003843
PMCPMC12474808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.